User Tools

Site Tools


documentation:cdm:drug_era

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
documentation:cdm:drug_era [2016/08/16 12:43]
cgreich [Conventions]
documentation:cdm:drug_era [2017/09/25 15:09] (current)
clairblacketer
Line 1: Line 1:
 ===== DRUG_ERA table ===== ===== DRUG_ERA table =====
 +**THIS IS OUTDATED. All documentation is now on the [[https://​github.com/​OHDSI/​CommonDataModel/​wiki|github wiki]]. Please refer there or to the [[projects:​workgroups:​cdm-wg|CDM working group]] for more information**
 +
 A Drug Era is defined as a span of time when the Person is assumed to be exposed to a particular active ingredient. A Drug Era is not the same as a Drug Exposure: Exposures are individual records corresponding to the source when Drug was delivered to the Person, while successive periods of Drug Exposures are combined under certain rules to produce continuous Drug Eras.  A Drug Era is defined as a span of time when the Person is assumed to be exposed to a particular active ingredient. A Drug Era is not the same as a Drug Exposure: Exposures are individual records corresponding to the source when Drug was delivered to the Person, while successive periods of Drug Exposures are combined under certain rules to produce continuous Drug Eras. 
 ^Field^Required^Type^Description^ ^Field^Required^Type^Description^
Line 22: Line 24:
   * The choice of a standard Persistence Window of 30 and the non-stockpiling assumption is arbitrary, but has been shown to deliver good results in drug-outcome estimation. Other problems, such as estimation of drug compliance, my require a different or drug-dependent Persistence Window/​stockpiling assumption. Researchers are encouraged to consider creating their own Drug Eras with different parameters as Cohorts and store them in the COHORT table.   * The choice of a standard Persistence Window of 30 and the non-stockpiling assumption is arbitrary, but has been shown to deliver good results in drug-outcome estimation. Other problems, such as estimation of drug compliance, my require a different or drug-dependent Persistence Window/​stockpiling assumption. Researchers are encouraged to consider creating their own Drug Eras with different parameters as Cohorts and store them in the COHORT table.
  
-{{:​documentation:​cdm:​drugera.jpg?​nolink&​300|Application to Drug Era rules to generation of two Lisinopril eras.}}+{{:​documentation:​cdm:​drugera.jpg?​nolink&​800|Application to Drug Era rules to generation of two Lisinopril eras.}}
documentation/cdm/drug_era.1471351421.txt.gz ยท Last modified: 2016/08/16 12:43 by cgreich